Annual Report

Overview

The report describes Almirall's 2014 transformation into a specialty pharmaceutical company following the AstraZeneca respiratory-franchise transaction, with total revenue of EUR 1,407.4 MM and strong dermatology growth. It also highlights more than 100,000 hours of employee training. Environmental initiatives included certified ISO 14001 and ISO 50001 management systems, waste-management activity, and energy-efficiency reductions.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2014
Period: 1 January 2014 – 31 December 2014
Language: English
Pages
File size

Materiality

Assessment
Basis

Assurance

Scope
Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services